IASLC Reviewer Workshop | IASLC
Improving Reviewer Performance.
Improving Reviewer Performance.
Exposure to propofol was associated with an increased risk of impairment in reaction time/processing speed at 1 year after treatment in children with high-risk B-cell…
Sharon Dent, Ph.D., professor of Epigenetics and Molecular Carcinogenesis, and dean of the Graduate School of Biomedical Sciences at The University of Texas MD Anderson…
Based on results from the phase 3 innovaTV 301 trial, the FDA has approved tisotumab vedotin for patients with recurrent or metastatic cervical cancer who…
The United States Preventive Services Task Force final breast cancer screening recommendation statement advises that women aged 40 begin biennial screening.
Ariel Lopez-Chavez, MD, discusses the potential of tarlatamab and its use in the frontline setting for the treatment of patients with small cell lung cancer.
Topline results from the REMOVE certification study showed that Lindis Blood Care’s medical device Catuvab was safe and effective, meeting all primary and secondary endpoints. …
Learn how advanced basal cell carcinoma can be treated with a new combination radiation and drug therapy.
A preclinical study suggests that the addition of a component of the ketogenic diet—a preketone dietary supplement—to immunotherapy may potentially be effective in treating prostate…
53 receive Dean’s Impact Awards for teaching, guiding, inspiring, advocating
Scientific detective work helped transform a previously shelved drug into a medicine now approved for relapsed or progressive pediatric low-grade glioma.